Related Experiment Video
Updated: Jun 4, 2026

05:42
Development of a Murine Model for Femoral Artery Anastomotic Stenosis
Published on: April 18, 2025
Pseudoangiomatous stromal hyperplasia: a case report
Yazan A Masannat1, Stephen Whitehead, Ian Hawley
1Department of General Surgery, Princess Royal University Hospital, Farnborough Common, Orpington BR6 8ND, UK.
Case Reports in Medicine
|February 15, 2011
Summary
Pseudoangiomatous stromal hyperplasia (PASH) is a rare benign breast condition. This case highlights a large PASH mimicking inflammatory carcinoma, successfully treated with excision.
Area of Science:
- Breast pathology
- Surgical oncology
Background:
- Pseudoangiomatous stromal hyperplasia (PASH) is a rare benign proliferation of mammary stroma.
- First described in 1986, PASH can present as a breast mass simulating vascular lesions.
- Literature reports of PASH remain infrequent.
Observation:
- A large PASH case is presented in a young female patient.
- The PASH mass mimicked the clinical presentation of inflammatory breast carcinoma.
- Surgical excision was performed for the breast lesion.
Findings:
- Histopathological examination confirmed pseudoangiomatous stromal hyperplasia.
- The lesion's size and presentation mimicked malignancy, posing a diagnostic challenge.
- Complete excision of the PASH was achieved.
Implications:
- This case underscores the importance of considering PASH in the differential diagnosis of breast masses, even those with concerning features.
- Early and accurate diagnosis is crucial for appropriate management and avoiding unnecessary aggressive treatments.
- Successful surgical excision can yield excellent cosmetic outcomes for benign breast conditions like PASH.
Related Concept Videos
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Cellular Adaptation III: Hyperplasia
Hyperplasia is an increase in the number of cells in a tissue or organ due to enhanced cell division. It is an adaptive, controlled response to stimuli such as injury, hormones, or stress, involving mitosis to produce genetically identical cells and support tissue repair and regeneration.Tissue CapacityCertain tissues, including the epidermis, intestinal epithelium, bone marrow, and fibroblasts, have a high potential for hyperplasia. Others, such as bone, cartilage, and smooth muscle, show...

